PBYI Dividend: Puma Biotechnology Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

PBYI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	211	230	235	228	253	225
Revenue Growth (YoY)	-13%	-2%	3%	-10%	12%	-17%
Cost of Revenue	48	64	62	55	63	39
Gross Profit	163	166	172	172	189	185
Selling, General & Admin	69	80	89	90	116	118
Research & Development	60	54	50	59	71	97
Operating Expenses	129	135	139	149	188	216
Other Non Operating Income (Expenses)	1	0	0	0	0	0
Pretax Income	30	24	22	0	-28	-59
Income Tax Expense	-6	-6	1	0	0	0
Net Income	36	30	21	0	-29	-60
Net Income Growth	56.99%	43%	--	-100%	-52%	-20%
Shares Outstanding (Diluted)	50.92	49.1	47.55	44.9	40.6	39.6
Shares Change (YoY)	4%	3%	6%	11%	3%	2%
EPS (Diluted)	0.74	0.61	0.45	0	-0.72	-1.52
EPS Growth	56%	36%	--	-100%	-53%	-22%
Free Cash Flow	42	38	14	-22	20	-19
Free Cash Flow Per Share	0.82	0.77	0.29	-0.48	0.49	-0.47
Gross Margin	77.25%	72.17%	73.19%	75.43%	74.7%	82.22%
Operating Margin	15.63%	13.04%	14.04%	10.08%	0.39%	-13.33%
Profit Margin	17.06%	13.04%	8.93%	0%	-11.46%	-26.66%
Free Cash Flow Margin	19.9%	16.52%	5.95%	-9.64%	7.9%	-8.44%
EBITDA	44	41	44	31	11	-20
EBITDA Margin	20.85%	17.82%	18.72%	13.59%	4.34%	-8.88%
D&A For EBITDA	11	11	11	8	10	10
EBIT	33	30	33	23	1	-30
EBIT Margin	15.63%	13.04%	14.04%	10.08%	0.39%	-13.33%
Effective Tax Rate	-20%	-25%	4.54%	0%	0%	0%